International Journal of Drug Development and Research

Research Scholar

Department of Medical Elementology and Toxicology

Jamia Hamdard (Hamdard University)

 India

Dr. Khan is working as a Scientist at the Institute of Nano Science and Technology (An Autonomous Institute supported by Department of Science & Technology, Govt. of India), Mohali, Punjab, India. He earned his MS and PhD degree in toxicology from Jamia Hamdard University. His work has published in 29 refereed research papers, attended about 8 workshops, trainings, national and international conferences. He is a Member of Royal Microscopical Society. He is already serving as a reviewer of many international reputed journals like Toxicological Sciences; Toxicology Letters; Amino Acids; BMC Complementary and Alternative Medicine; Food and Chemical Toxicology; Basic and Clinical Pharmacology and Toxicology; Molecular and Cellular Biochemistry; Human and Experimental Toxicology; Toxicology In-Vitro; Toxicology Mechanisms and Methods; Journal of Pharmacy and Pharmacology; Cell Biochemistry and Function and as an Editorial Board member of Research & Reviews: Journal of Pharmaceutics and Nanotechnology.

Dr. Khan is working in the field of Cancer Biology and Toxicology. His area of research includes Cancer Biology, Synthetic Lethality and Cancer, Nano-Chemoprevention of cancer and identification of natural compound for amelioration of toxicity of chemotherapeutic drug. His main research interest is to develop novel drug targets for cancer treatment by exploiting Chromosomal instability (CIN) genes. These CIN genes are cancer cell specific signatures and can be used for the selective killing of cancer cells. During his post-doctoral training from CancerCare Manitoba, University of Manitoba, Canada, he has been working on to develop synthetic lethal interactors of homologous recombination repair (HRR)-deficient cancer cells for synergistic killing of cancer cells only, sparing normal cells. During his PhD, he has been working on colorectal cancer chemoprevention and evaluation of potency of natural compounds could be used as a combination agent with chemotherapeutic drugs which could reduce anti-cancer drug toxicity.